nach oben

Journal of Cancer Research and Clinical Oncology

Erschienen in:

11.06.2021 | Review – Cancer Research

Exploring polyps to colon carcinoma voyage: can blocking the crossroad halt the sequence?

verfasst von: Abdul Arif Khan

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 8/2021

Einloggen, um Zugang zu erhalten

Abstract

Colorectal cancer is an important public health concern leading to significant cancer associate mortality. A vast majority of colon cancer arises from polyp which later follows adenoma, adenocarcinoma, and carcinoma sequence. This whole process takes several years to complete and recent genomic and proteomic technologies are identifying several targets involved in each step of polyp to carcinoma transformation in a large number of studies. Current text presents interaction network of targets involved in polyp to carcinoma transformation. In addition, important targets involved in each step according to network biological parameters are also presented. The functional overrepresentation analysis of each step targets and common top biological processes and pathways involved in carcinoma indicate several insights about this whole mechanism. Interaction networks indicate TP53, AKT1, GAPDH, INS, EGFR, and ALB as the most important targets commonly involved in polyp to carcinoma sequence. Though several important pathways are known to be involved in CRC, the central common involvement of PI3K-AKT indicates its potential for devising CRC management strategies. The common and central targets and pathways involved in polyp to carcinoma progression can shed light on its mechanism and potential management strategies. The data-driven approach aims to add valuable inputs to the mechanism of the years-long polyp-carcinoma sequence.

Nur mit Berechtigung zugänglich

Aarons CB, Shanmugan S, Bleier JI (2014) Management of malignant colon polyps: current status and controversies. World J Gastroenterol 20(43):16178–16183. https://doi.org/10.3748/wjg.v20.i43.16178CrossRefPubMedPubMedCentral

Armaghany T, Wilson JD, Chu Q, Mills G (2012) Genetic alterations in colorectal cancer. Gastrointest Cancer Res GCR 5(1):19–27PubMed

Baandrup L, Thomsen LT, Olesen TB, Andersen KK, Norrild B, Kjaer SK (2014) The prevalence of human papillomavirus in colorectal adenomas and adenocarcinomas: a systematic review and meta-analysis. Eur J Cancer 50(8):1446–1461. https://doi.org/10.1016/j.ejca.2014.01.019CrossRefPubMed

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424. https://doi.org/10.3322/caac.21492CrossRefPubMed

Bronner MP, Haggitt RC (1993) The polyp-cancer sequence: do all colorectal cancers arise from benign adenomas? Gastrointest Endosc Clin N Am 3(4):611–622. https://doi.org/10.1016/S1052-5157(18)30534-8CrossRef

Bujanda L, Cosme A, Gil I, Arenas-Mirave JI (2010) Malignant colorectal polyps. World J Gastroenterol 16(25):3103–3111. https://doi.org/10.3748/wjg.v16.i25.3103CrossRefPubMedPubMedCentral

Busher JT (1990) Serum albumin and globulin. In: Walker HK, Hall WD, Hurst JW (eds) Clinical methods: the history, physical, and laboratory examinations

Butera G, Pacchiana R, Mullappilly N, Margiotta M, Bruno S, Conti P, Riganti C (2018) Mutant p53 prevents GAPDH nuclear translocation in pancreatic cancer cells favoring glycolysis and 2-deoxyglucose sensitivity. Biochim Biophys Acta 12:1914–1923. https://doi.org/10.1016/j.bbamcr.2018.10.005CrossRef

Cancer Genome Atlas N (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487(7407):330–337. https://doi.org/10.1038/nature11252CrossRef

Caraceni P, Tufoni M, Bonavita ME (2013) Clinical use of albumin. Blood Transf 11:18–25. https://doi.org/10.2450/2013.005sCrossRef

Chavali LB, Hu K, Sheth A, Gao N, Xiong W, Zhang L (2020) Colorectal sessile serrated lesion with large size or synchronous neoplasm: a prospective study. Eur J Gastroenterol Hepatol 32(2):199–204. https://doi.org/10.1097/MEG.0000000000001642CrossRefPubMedPubMedCentral

Chen Z, Wang C, Dong H, Wang X, Gao F, Zhang S, Zhang X (2020) Aspirin has a better effect on PIK3CA mutant colorectal cancer cells by PI3K/Akt/Raptor pathway. Mol Med 26(1):14. https://doi.org/10.1186/s10020-020-0139-5CrossRefPubMedPubMedCentral

Cho Y-H, Ro EJ, Yoon J-S, Mizutani T, Kang D-W, Park J-C, Il Kim T, Clevers H, Choi K-Y (2020) 5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation. Nat Commun 11(1):5321. https://doi.org/10.1038/s41467-020-19173-2CrossRefPubMedPubMedCentral

Damin DC, Caetano MB, Rosito MA, Schwartsmann G, Damin AS, Frazzon AP, Ruppenthal RD, Alexandre CO (2007) Evidence for an association of human papillomavirus infection and colorectal cancer. Eur J Surg Oncol 33(5):569–574. https://doi.org/10.1016/j.ejso.2007.01.014CrossRefPubMed

Damin DC, Ziegelmann PK, Damin AP (2013) Human papillomavirus infection and colorectal cancer risk: a meta-analysis. Colorec Dis 15(8):e420-428. https://doi.org/10.1111/codi.12257CrossRef

De Rosa M, Rega D, Costabile V, Duraturo F, Niglio A, Izzo P, Pace U, Delrio P (2016) The biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized care. Ther Adv Gastroenterol 9(6):861–886. https://doi.org/10.1177/1756283X16659790CrossRef

Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61(5):759–767. https://doi.org/10.1016/0092-8674(90)90186-iCrossRefPubMed

Fornito A, Zalesky A, Bullmore ET (2016) Chapter 4 - Node Degree and Strength. In: Fornito A, Zalesky A, Bullmore ET (eds) Fundamentals of Brain Network Analysis. Academic Press, San Diego. https://doi.org/10.1016/B978-0-12-407908-3.00004-2CrossRef

Giovannucci E (1995) Insulin and colon cancer. Cancer Causes Control CCC 6(2):164–179. https://doi.org/10.1007/BF00052777CrossRefPubMed

Giovannucci E (2001) Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 131(11 Suppl):3109S-3120S. https://doi.org/10.1093/jn/131.11.3109SCrossRefPubMed

Giovannucci E (2007) Metabolic syndrome, hyperinsulinemia, and colon cancer: a review. Am J Clin Nutr 86(3):s836-842. https://doi.org/10.1093/ajcn/86.3.836SCrossRefPubMed

Gonzalez-Trejo S, Carrillo JF, Carmona-Herrera DD, Baz-Gutierrez P, Herrera-Goepfert R, Nunez G, Ochoa-Carrillo FJ, Gallardo-Rincon D, Aiello-Crocifoglio V, Onate-Ocana LF (2017) Baseline serum albumin and other common clinical markers are prognostic factors in colorectal carcinoma: a retrospective cohort study. Medicine 96(15):e6610. https://doi.org/10.1097/MD.0000000000006610CrossRefPubMedPubMedCentral

He X, Zhang J (2006) Why do hubs tend to be essential in protein networks? PLoS Genet 2(6):e88. https://doi.org/10.1371/journal.pgen.0020088CrossRefPubMedPubMedCentral

Hirata T, Nakamoto M, Nakamura M, Kinjo N, Hokama A, Kinjo F, Fujita J (2007) Low prevalence of human T cell lymphotropic virus type 1 infection in patients with gastric cancer. J Gastroenterol Hepatol 22(12):2238–2241. https://doi.org/10.1111/j.1440-1746.2006.04740.xCrossRefPubMed

Iacopetta B (2003) TP53 mutation in colorectal cancer. Hum Mutat 21(3):271–276. https://doi.org/10.1002/humu.10175CrossRefPubMed

Johnston L, Carey F (2020) Pathology of colorectal polyps and cancer. Surg Infect (larchmt) 38(1):12–17. https://doi.org/10.1016/j.mpsur.2019.10.012CrossRef

Jung G, Hernandez-Illan E, Moreira L, Balaguer F, Goel A (2020) Epigenetics of colorectal cancer: biomarker and therapeutic potential. Nat Rev Gastroenterol Hepatol 17(2):111–130. https://doi.org/10.1038/s41575-019-0230-yCrossRefPubMedPubMedCentral

Kamarudin MNA, Sarker MMR, Zhou JR, Parhar I (2019) Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects. J Exp Clin Cancer Res CR 38(1):491. https://doi.org/10.1186/s13046-019-1495-2CrossRefPubMed

Khan AA, Khan Z, Malik A, Kalam MA, Cash P, Ashraf MT, Alshamsan A (2017) Colorectal cancer-inflammatory bowel disease nexus and felony of Escherichia coli. Life Sci 180:60–67. https://doi.org/10.1016/j.lfs.2017.05.016CrossRefPubMed

Knekt P, Hakulinen T, Leino A, Heliovaara M, Reunanen A, Stevens R (2000) Serum albumin and colorectal cancer risk. Eur J Clin Nutr 54(6):460–462. https://doi.org/10.1038/sj.ejcn.1600997CrossRefPubMed

Krasinskas AM (2011) EGFR signaling in colorectal carcinoma. Pathol Res Int 2011:932932. https://doi.org/10.4061/2011/932932CrossRef

Kuipers EJ, Grady WM, Lieberman D, Seufferlein T, Sung JJ, Boelens PG, van de Velde CJH, Watanabe T (2015) Colorectal cancer. Nat Rev Dis Primers 1(1):15065. https://doi.org/10.1038/nrdp.2015.65CrossRefPubMedPubMedCentral

Leslie A, Carey FA, Pratt NR, Steele RJ (2002) The colorectal adenoma-carcinoma sequence. Br J Surg 89(7):845–860. https://doi.org/10.1046/j.1365-2168.2002.02120.xCrossRefPubMed

Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, Levin TR (2012) Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 143(3):844–857. https://doi.org/10.1053/j.gastro.2012.06.001CrossRefPubMed

Matsumoto S, Yamasaki K, Tsuji K, Shirahama S (2008) Human T lymphotropic virus type 1 infection and gastric cancer development in Japan. J Infect Dis 198(1):10–15. https://doi.org/10.1086/588733CrossRefPubMed

Nazha B, Moussaly E, Zaarour M, Weerasinghe C, Azab B (2015) Hypoalbuminemia in colorectal cancer prognosis: nutritional marker or inflammatory surrogate? World J Gastrointest Surg 7(12):370–377. https://doi.org/10.4240/wjgs.v7.i12.370CrossRefPubMedPubMedCentral

Pan J, Cen L, Xu L, Miao M, Li Y, Yu C, Shen Z (2020) Prevalence and risk factors for colorectal polyps in a Chinese population: a retrospective study. Sci Rep 10(1):6974. https://doi.org/10.1038/s41598-020-63827-6CrossRefPubMedPubMedCentral

Pavlopoulou A, Spandidos DA, Michalopoulos I (2015) Human cancer databases (review). Oncol Rep 33(1):3–18. https://doi.org/10.3892/or.2014.3579CrossRefPubMed

Pinero J, Ramirez-Anguita JM, Sauch-Pitarch J, Ronzano F, Centeno E, Sanz F, Furlong LI (2020) The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Res 48(D1):D845–D855. https://doi.org/10.1093/nar/gkz1021CrossRefPubMed

Pino MS, Chung DC (2010) The chromosomal instability pathway in colon cancer. Gastroenterology 138(6):2059–2072. https://doi.org/10.1053/j.gastro.2009.12.065CrossRefPubMed

Raudvere U, Kolberg L, Kuzmin I, Arak T, Adler P, Peterson H, Vilo J (2019) g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update). Nucleic Acids Res 47(W1):W191–W198. https://doi.org/10.1093/nar/gkz369CrossRefPubMedPubMedCentral

Rutter MD, East J, Rees CJ, Cripps N, Docherty J, Dolwani S, Kaye PV, Monahan KJ, Novelli MR, Plumb A, Saunders BP, Thomas-Gibson S, Tolan DJM, Whyte S, Bonnington S, Scope A, Wong R, Hibbert B, Marsh J, Moores B, Cross A, Sharp L (2020) British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines. Gut 69(2):201–223. https://doi.org/10.1136/gutjnl-2019-319858CrossRefPubMed

Seo HA, Moeng S, Sim S, Kuh HJ, Choi SY, Park JK (2019) MicroRNA-based combinatorial cancer therapy: effects of microRNAs on the efficacy of anti-cancer therapies. Cells. https://doi.org/10.3390/cells9010029CrossRefPubMedPubMedCentral

Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13(11):2498–2504. https://doi.org/10.1101/gr.1239303CrossRefPubMedPubMedCentral

Siddiqui AA (2011) Metabolic syndrome and its association with colorectal cancer: a review. Am J Med Sci 341(3):227–231. https://doi.org/10.1097/MAJ.0b013e3181df9055CrossRefPubMed

Spano JP, Lagorce C, Atlan D, Milano G, Domont J, Benamouzig R, Attar A, Benichou J, Martin A, Morere JF, Raphael M, Penault-Llorca F, Breau JL, Fagard R, Khayat D, Wind P (2005) Impact of EGFR expression on colorectal cancer patient prognosis and survival. Ann Oncol 16(1):102–108. https://doi.org/10.1093/annonc/mdi006CrossRefPubMed

Stelzer G, Rosen N, Plaschkes I, Zimmerman S, Twik M, Fishilevich S, Stein TI, Nudel R, Lieder I, Mazor Y, Kaplan S, Dahary D, Warshawsky D, Guan-Golan Y, Kohn A, Rappaport N, Safran M, Lancet D (2016) The GeneCards suite: From gene data mining to disease genome sequence analyses. Curr Protoc Bioinform. https://doi.org/10.1002/cpbi.5CrossRef

Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P, Jensen LJ, Mering CV (2019) STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 47(D1):D607–D613. https://doi.org/10.1093/nar/gky1131CrossRefPubMed

Tang Z, Yuan S, Hu Y, Zhang H, Wu W, Zeng Z, Yang J, Yun J, Xu R, Huang P (2012) Over-expression of GAPDH in human colorectal carcinoma as a preferred target of 3-bromopyruvate propyl ester. J Bioenerg Biomembr 44(1):117–125. https://doi.org/10.1007/s10863-012-9420-9CrossRefPubMedPubMedCentral

Tarrado-Castellarnau M, Diaz-Moralli S, Polat IH, Sanz-Pamplona R, Alenda C, Moreno V, Castells A, Cascante M (2017) Glyceraldehyde-3-phosphate dehydrogenase is overexpressed in colorectal cancer onset. Transl Med Commun 2(1):6. https://doi.org/10.1186/s41231-017-0015-7CrossRef

Vivanco I, Sawyers CL (2002) The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2(7):489–501. https://doi.org/10.1038/nrc839CrossRefPubMed

Weng M-l, Chen W-k, Chen X-y, Lu H, Sun Z-r, Yu Q, Sun P-f, Xu Y-j, Zhu M-m, Jiang N, Zhang J, Zhang J-p, Song Y-l, Ma D, Zhang X-p, Miao C-h (2020) Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression. Nat Commun 11(1):1869. https://doi.org/10.1038/s41467-020-15795-8CrossRefPubMedPubMedCentral

Zauber AG, Winawer SJ, O’Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, Hankey BF, Shi W, Bond JH, Schapiro M, Panish JF, Stewart ET, Waye JD (2012) Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 366(8):687–696. https://doi.org/10.1056/NEJMoa1100370CrossRefPubMedPubMedCentral

Zhang JY, Zhang F, Hong CQ, Giuliano AE, Cui XJ, Zhou GJ, Zhang GJ, Cui YK (2015) Critical protein GAPDH and its regulatory mechanisms in cancer cells. Cancer Biol Med 12(1):10–22. https://doi.org/10.7497/j.issn.2095-3941.2014.0019CrossRefPubMedPubMedCentral

Zhang S, Deng Z, Yao C, Huang P, Zhang Y, Cao S, Li X (2017) AT7867 inhibits human colorectal cancer cells via AKT-dependent and AKT-independent mechanisms. PLoS ONE 12(1):e0169585. https://doi.org/10.1371/journal.pone.0169585CrossRefPubMedPubMedCentral

Zhang XH, Wang W, Wang YQ, Jia DF, Zhu L (2018) Human papillomavirus infection and colorectal cancer in the Chinese population: a meta-analysis. Colorec Dis 20(11):961–969. https://doi.org/10.1111/codi.14416CrossRef

Zhao X, Liu ZP (2019) Analysis of topological parameters of complex disease genes reveals the importance of location in a biomolecular network. Genes. https://doi.org/10.3390/genes10020143CrossRefPubMedPubMedCentral

Zhu J, Xu Y, Liu S, Qiao L, Sun J, Zhao Q (2020) MicroRNAs associated with colon cancer: new potential prognostic markers and targets for therapy. Front Bioeng Biotechnol 8:176. https://doi.org/10.3389/fbioe.2020.00176CrossRefPubMedPubMedCentral

Titel: Exploring polyps to colon carcinoma voyage: can blocking the crossroad halt the sequence?
verfasst von: Abdul Arif Khan
Publikationsdatum: 11.06.2021
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Cancer Research and Clinical Oncology / Ausgabe 8/2021
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI: https://doi.org/10.1007/s00432-021-03685-5

Springer Medizin

Exploring polyps to colon carcinoma voyage: can blocking the crossroad halt the sequence?

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2021

Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancer

Expression of ISL1 and its partners in prostate cancer progression and neuroendocrine differentiation

Aurora B kinase: a potential drug target for cancer therapy

The ability of post-chemoradiotherapy DWI ADCmean and 18F-FDG SUVmax to predict treatment outcomes in head and neck cancer: impact of human papilloma virus oropharyngeal cancer status

Treatment stage migration and treatment sequences in patients with hepatocellular carcinoma: drawbacks and opportunities

Angiogenesis and chemotherapy resistance: optimizing chemotherapy scheduling using mathematical modeling

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie